CYTEK BIOSCIENCES INC (CTKB) Stock Price & Overview
NASDAQ:CTKB • US23285D1090
Current stock price
The current stock price of CTKB is 4.655 USD. Today CTKB is up by 0.54%. In the past month the price decreased by -1.7%. In the past year, price increased by 22.81%.
CTKB Key Statistics
- Market Cap
- 598.4M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.21
- Dividend Yield
- N/A
CTKB Stock Performance
CTKB Stock Chart
CTKB Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to CTKB. When comparing the yearly performance of all stocks, CTKB turns out to be only a medium performer in the overall market: it outperformed 48.73% of all stocks.
CTKB Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CTKB. The financial health of CTKB is average, but there are quite some concerns on its profitability.
CTKB Earnings
On February 26, 2026 CTKB reported an EPS of -0.04 and a revenue of 62.14M. The company missed EPS expectations (-96.08% surprise) and beat revenue expectations (6.53% surprise).
CTKB Forecast & Estimates
11 analysts have analysed CTKB and the average price target is 6.12 USD. This implies a price increase of 31.47% is expected in the next year compared to the current price of 4.655.
For the next year, analysts expect an EPS growth of 20.67% and a revenue growth 5.81% for CTKB
CTKB Groups
Sector & Classification
CTKB Financial Highlights
Over the last trailing twelve months CTKB reported a non-GAAP Earnings per Share(EPS) of -0.21. The EPS decreased by -320% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -14.42% | ||
| ROE | -19.47% | ||
| Debt/Equity | 0 |
CTKB Ownership
CTKB Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.82 | 194.941B | ||
| DHR | DANAHER CORP | 20.09 | 137.676B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 142.85 | 48.612B | ||
| A | AGILENT TECHNOLOGIES INC | 18.03 | 34.503B | ||
| WAT | WATERS CORP | 22.9 | 32.91B | ||
| IQV | IQVIA HOLDINGS INC | 13.68 | 29.493B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 27.96 | 26.817B | ||
| ILMN | ILLUMINA INC | 24.81 | 20.049B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 33.96 | 19.802B | ||
| MEDP | MEDPACE HOLDINGS INC | 29.03 | 14.706B | ||
| RVTY | REVVITY INC | 17.17 | 10.539B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.894B | ||
| TECH | BIO-TECHNE CORP | 26.24 | 9.335B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CTKB
Company Profile
Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. The company is headquartered in Fremont, California and currently employs 702 full-time employees. The company went IPO on 2021-07-23. The firm is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
Company Info
IPO: 2021-07-23
CYTEK BIOSCIENCES INC
47215 Lakeview Boulevard
Fremont CALIFORNIA US
Employees: 702
Phone: 18779229835
CYTEK BIOSCIENCES INC / CTKB FAQ
What does CYTEK BIOSCIENCES INC do?
Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. The company is headquartered in Fremont, California and currently employs 702 full-time employees. The company went IPO on 2021-07-23. The firm is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
What is the current price of CTKB stock?
The current stock price of CTKB is 4.655 USD. The price increased by 0.54% in the last trading session.
What is the dividend status of CYTEK BIOSCIENCES INC?
CTKB does not pay a dividend.
What is the ChartMill technical and fundamental rating of CTKB stock?
CTKB has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the PE ratio for CTKB stock?
CYTEK BIOSCIENCES INC (CTKB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.21).
Is CYTEK BIOSCIENCES INC (CTKB) expected to grow?
The Revenue of CYTEK BIOSCIENCES INC (CTKB) is expected to grow by 5.81% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for CYTEK BIOSCIENCES INC?
CYTEK BIOSCIENCES INC (CTKB) has a market capitalization of 598.40M USD. This makes CTKB a Small Cap stock.